HCM FY 2024 Earnings — HUTCHMED (China) Limited Revenue & Financial Results | Market Cap Arena

HCMHUTCHMED (China) Limited

$3B

FY 2024 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$630M-24.8% YoY

Gross Profit

$281M44.6% margin

Operating Income

-$44M-6.9% margin

Net Income

$38M6.0% margin

EPS (Diluted)

$0.22

Cash Flow

Operating Cash Flow

$497,000

Free Cash Flow

-$17M

Stock-Based Comp.

$22M

Balance Sheet

Total Assets

$1.3B

Total Liabilities

$502M

Stockholders' Equity

$760M

Cash & Equivalents

$154M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$630M	$838M	-24.8%
Gross Profit	$281M	$454M	-38.0%
Operating Income	-$44M	$18M	-337.9%
Net Income	$38M	$101M	-62.6%